Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
9(75.0%)
Phase 4
2(16.7%)
Phase 1
1(8.3%)
12Total
N/A(9)
Phase 4(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT07130968Enrolling By Invitation

Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform

Role: collaborator

NCT07237828Not ApplicableNot Yet Recruiting

Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR

Role: collaborator

NCT07235345Not ApplicableEnrolling By Invitation

To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation

Role: collaborator

NCT07202234Not ApplicableNot Yet Recruiting

Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT06857344Not ApplicableRecruiting

Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

Role: collaborator

NCT06728839Not ApplicableNot Yet Recruiting

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Role: collaborator

NCT05431075Phase 4Completed

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Role: collaborator

NCT05794425Phase 1Recruiting

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Role: collaborator

NCT05870683Not ApplicableUnknown

Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)

Role: collaborator

NCT05432115Phase 4Unknown

Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Role: collaborator

NCT05620602Unknown

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

Role: collaborator

NCT04720521Not ApplicableUnknown

Application of OE in Diagnosis of EGC

Role: collaborator

NCT03406832Not ApplicableUnknown

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

Role: collaborator

NCT03406819Not ApplicableUnknown

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI

Role: collaborator

All 15 trials loaded